Results
134
Most Popular Stocks on the market
134 companies
Locus Cell
Market Cap: NT$6.8b
Focuses on contract development and manufacturing organization (CDMO) services for cell products in Taiwan and internationally.
6891
NT$34.15
7D
10.2%
1Y
21.1%
OBI Pharma
Market Cap: NT$6.8b
A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.
4174
NT$25.95
7D
-1.9%
1Y
-64.6%
TaiGen Biopharmaceuticals Holdings
Market Cap: NT$6.4b
A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.
4157
NT$8.86
7D
1.0%
1Y
-38.9%
Panion & Bf Biotech
Market Cap: NT$6.1b
A biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally.
1760
NT$71.00
7D
0.7%
1Y
-20.3%
Pharmosa Biopharm
Market Cap: NT$6.0b
A biotechnology company, focuses on developing drugs in Taiwan.
6875
NT$46.20
7D
0%
1Y
-25.0%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.9b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$30.90
7D
1.3%
1Y
-0.8%
Savior Lifetec
Market Cap: NT$5.7b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$17.90
7D
-0.8%
1Y
-16.0%
Easywell Biomedicals
Market Cap: NT$5.7b
Develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America.
1799
NT$45.50
7D
-0.7%
1Y
-65.8%
Orient Pharma
Market Cap: NT$5.7b
Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.
4166
NT$25.40
7D
-2.3%
1Y
-1.6%
Intelligene
Market Cap: NT$5.6b
Engages in the development of RNA gene therapy drugs for infectious diseases.
7832
NT$9.67
7D
-2.2%
1Y
n/a
UnicoCell Biomed
Market Cap: NT$5.5b
Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.
6794
NT$90.10
7D
11.8%
1Y
15.8%
Sunhawk Vision Biotech
Market Cap: NT$5.2b
Operates as a drug development company that develops microRNA therapeutic eye drops.
7759
NT$73.70
7D
-6.4%
1Y
n/a
BioGend Therapeutics
Market Cap: NT$5.0b
Researches, develops, and sells orthopedic medical equipment and related products.
6733
NT$40.05
7D
-2.3%
1Y
5.7%
Cenra
Market Cap: NT$5.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$33.90
7D
1.5%
1Y
-13.7%
Energenesis BiomedicalLTD
Market Cap: NT$4.8b
Operates in the biomedicine industry in Taiwan.
6657
NT$53.60
7D
0%
1Y
2.1%
StemCyte International
Market Cap: NT$4.7b
Operates cord blood cell banks in the United States and Taiwan.
4178
NT$24.40
7D
-3.2%
1Y
n/a
Formosa Pharmaceuticals
Market Cap: NT$4.6b
A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.
6838
NT$30.65
7D
-0.8%
1Y
-28.3%
Pet Pharm Biotech
Market Cap: NT$4.6b
Manufactures and sells pharmaceutical products.
7762
NT$90.00
7D
11.2%
1Y
144.2%
SunWay Biotech
Market Cap: NT$4.6b
Focuses on professional research and development, and technical material manufacturing and processing business.
1271
NT$76.00
7D
1.5%
1Y
-11.0%
ACRO Biomedical
Market Cap: NT$4.5b
Develops medical-grade regenerative biomaterials.
6748
NT$73.90
7D
1.9%
1Y
189.8%
AnnJi Pharmaceutical
Market Cap: NT$4.5b
Develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.
7754
NT$47.60
7D
3.7%
1Y
35.0%
Orient EuroPharma
Market Cap: NT$4.4b
A pharmaceutical company, develops and manufactures drugs worldwide.
4120
NT$50.80
7D
0.2%
1Y
2.5%
Yoda Pharmaceuticals
Market Cap: NT$4.2b
An AI-driven company, focuses on advancing drug research and development targeting central nervous system disorders.
7829
NT$53.50
7D
5.3%
1Y
n/a
Synbio Tech
Market Cap: NT$4.2b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$122.50
7D
-11.9%
1Y
33.9%
BRIM Biotechnology
Market Cap: NT$4.2b
A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.
6885
NT$31.85
7D
-0.9%
1Y
-31.5%
Bonraybio
Market Cap: NT$4.2b
A development stage company, manufactures medical instruments and solutions for the male infertility market.
6955
NT$167.50
7D
-0.9%
1Y
45.9%
Medigen Biotechnology
Market Cap: NT$4.0b
A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.
3176
NT$29.05
7D
-0.5%
1Y
-24.0%
BIONET Therapeutics
Market Cap: NT$4.0b
A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.
7808
NT$57.00
7D
5.6%
1Y
n/a
Protect Animal Health
Market Cap: NT$3.9b
Engages in the development of therapeutic vaccines for the animals.
7850
NT$39.65
7D
-4.5%
1Y
n/a
3D Global Biotech
Market Cap: NT$3.8b
Develops medical materials for human body reconstruction in China.
6808
NT$49.00
7D
-1.7%
1Y
26.1%
Nang Kuang Pharmaceutical
Market Cap: NT$3.8b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$37.70
7D
-2.2%
1Y
-15.1%
Shine-On BioMedicalLtd
Market Cap: NT$3.7b
Research, develops, and manufactures anti-cancer related drug products.
6926
NT$75.20
7D
2.2%
1Y
17.9%
Maxigen Biotech
Market Cap: NT$3.7b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$45.50
7D
-0.2%
1Y
7.1%
Senhwa Biosciences
Market Cap: NT$3.6b
A drug development company, engages in the development of new drugs and targeted agents.
6492
NT$39.90
7D
5.8%
1Y
-23.1%
TWi Biotechnology
Market Cap: NT$3.5b
A clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan.
6610
NT$32.85
7D
-1.9%
1Y
143.3%
Sinew Pharma
Market Cap: NT$3.4b
A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.
6634
NT$47.65
7D
4.4%
1Y
-25.0%